DIOSNA Dierks & Söhne GmbH - Granulationline CGS - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

DIOSNA Dierks & Söhne GmbH - Granulationline CGS


The CGS concept provides optimal integration of the process steps of mixing, granulating and drying. The outlet of the mixer-granulator is directly linked to the inlet of the fluid bed dryer, eliminating long transfer pipes.

Installation expenditure for the CGS is low. Mixer and dryer are supported by one common frame which makes additional framework unnecessary.

The CGS concept can incorporate an integrated explosion protection concept. The individual processing units of mixer, wet mill and dryer will then be designed to be 12 bar pressure shock resistant.

Due to the compact installation, the floor space required by the CGS plant is very small. This fact is not only important for existing plants with limited available space, but also for new plants which allows clean room space to be reduced.

All connection lines of the CGS from feeding the mixer to discharging the dryer are integrated into the automatic cleaning system. Due to well planned accessibility of all areas the supply lines can be connected in minimal time.

Website: www.diosna.com

E-mail: info@diosna.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here